Katrina Jackson on Muck Rack

Katrina Jackson

United States
As seen in: AORN Journal, Color Research & Application, Nature, MDPI, ACS Publications, Texas Lawyer, EIN News, JD Supra, American Society for Microbiology (ASM), EIN Presswire and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Katrina

Contact Katrina, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9

|
By Katrina Jackson, Ning Yin, Roman V Agafonov, Prasoon Chaturvedi
Open in Who Shared Issue with article?

Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9

|
By Katrina Jackson, Ning Yin, Roman V Agafonov, Prasoon Chaturvedi
| ACS Publications
Cite Jump to ExpandCollapse Drug AnnotationNovember 24, 2025 Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9 Click to copy article linkArticle link copied! Katrina L. Jackson* Katrina L. Jackson C4 Therapeutics, Inc., 490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472, United States *Email: [email protected] Ning Yin Ning Yin C4 Therapeutics, Inc., 490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472, United States Roman V.
Open in Who Shared Issue with article?

BiDAC-dependent degradation of plasma membrane proteins by the endolysosomal system - Nature Communications

|
By Sammy Villa, Julia R. Lazzari-Dean, Niclas Olsson, Katrina Jackson, Aaron H. Nile
| Nature
Abstract The discovery of bifunctional degradation activating compounds (BiDACs) has led to the development of a new class of drugs that promote the clearance of their protein targets. BiDAC-induced ubiquitination is generally believed to direct cytosolic and nuclear proteins to proteolytic destruction by proteasomes. However, pathways that govern the degradation of other classes of BiDAC targets, such as integral membrane and intraorganellar proteins, have not been investigated in depth.
Open in Who Shared Issue with article?
See all 14 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Katrina

Contact Katrina, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified